In April 2009, a new line of medical autoclave – the BRAVO series – received FDA approval to proceed with marketing. The new sterilization product was developed by SciCan Ltd.in Canada and is just now making its rounds in the US. These are table top vacuum steam sterilizers that operate at high pressures. This optimizes the conditions necessary to penetrate a load and effectively kill infectious organisms in a short period of time.
More>>
On June 18th, Getinge USA, Inc. received the 2009 Suppliers Performance Award. This is an honor bestowed by Premier, Inc. – a coalition of 60,000 healthcare facilities and hospitals across the U.S. Premier is dedicated to improving performance in the health field in measurable ways. Collecting data and evaluating outcomes is one of the things they do best. An award from this organization is based on an in depth review of a full 12 months of data and is a real marker of achievement.
More>>
The resiliency of Acinetobacter bacteria has been known since it was first studied in 1973 after being brought back from Vietnam by soldiers. At that time, the spread of this infectious agent could easily be controlled with common antibiotics. Today the pathogen can be found in the soil and in water sources across the U.S. Unfortunately, it has also acquired multidrug resistance. This germ generally attacks people who are vulnerable because of traumatic injury or a compromised immune system.
More>>
In June, a 3M study published in Healthcare Purchasing News drew attention to the phenomenon of Toxic Anterior Segment Syndrome (TASS). This condition is also known as toxic endothelial cell destruction. It has been associated with sterilization residue in many cases where cataract eye surgery has failed.
More>>
